• Celgene Corp., of Summit, N.J., once again beat analyst expectations for the quarter. The firm reported third quarter revenues of $1.25 billion, a 37 percent increase over the same period last year and ahead of the $1.2 billion analysts had expected. Non-GAAP net income was $469 million and non-GAAP earnings per share were $1.02, while analysts had expected 94 cents.